Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-16 | 2021-09-30 | 120473 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-27 | 2023-06-09 | 190728 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138294 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2024-06-07 | 2025-04-28 | 229945 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2022-02-17 | 2022-03-24 | 155152 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2021-03-25 | 2021-04-01 | 136314 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2024-04-25 | 2025-03-13 | 226174 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86846 |
| TEVA-BUSPIRONE | 10MG | TABLET | Actual shortage | 2025-11-20 | 2026-01-15 | 272295 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-01-19 | 2023-04-28 | 181605 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-06-08 | 2023-10-19 | 194154 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-06-16 | 2023-07-28 | 195115 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-02-07 | 2020-06-11 | 105583 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2019-08-22 | 2019-11-01 | 92192 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-01-19 | 2023-06-09 | 181599 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2019-06-27 | 2019-11-01 | 87690 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2022-09-30 | 2022-12-22 | 170792 |
| TEVA-CANDESARTAN | 32MG | TABLET | Actual shortage | 2026-01-08 | 2026-01-09 | 275527 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183413 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2020-07-16 | 2020-08-21 | 120476 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT VENLAFAXINE XR | 75.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65295 |
| ACT VENLAFAXINE XR | 150.0MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65305 |
| ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65213 |
| ACT ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65218 |
| ACT ZOPICLONE | 5MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65191 |
| AERMONY RESPICLICK | 232MCG | POWDER (METERED DOSE) | Discontinued | 2025-09-02 | 2025-09-02 | 266350 |
| AERMONY RESPICLICK | 113MCG | POWDER (METERED DOSE) | Discontinued | 2025-05-28 | 2025-05-28 | 258571 |
| AERMONY RESPICLICK | 55MCG | POWDER (METERED DOSE) | Discontinued | 2024-11-05 | 2024-11-05 | 242101 |
| ALERTEC | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258777 |
| ALLERNIX | 25MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258595 |
| ALLERNIX EXTRA STRENGTH | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258562 |
| AZILECT | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258771 |
| AZILECT | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258705 |
| BALMINIL DM (3MG/ML SUCROSE FREE) | 15MG | SYRUP | Discontinued | 2025-05-28 | 2025-05-28 | 258741 |
| BALMINIL EXPECTORANT (SUCROSE FREE) | 100MG | SYRUP | Discontinued | 2025-05-28 | 2025-05-28 | 258750 |
| BORTEZOMIB FOR INJECTION | 3.5MG | POWDER FOR SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256094 |
| CALMYLIN ACE | 10MG 7.5MG 100MG | SYRUP | Discontinued | 2024-06-28 | 2024-06-29 | 231574 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
| CEFAZOLIN FOR INJECTION | 0.5G | POWDER FOR SOLUTION | Discontinued | 2019-08-08 | 2019-08-08 | 91175 |
| CEFOXITIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2020-05-14 | 2020-05-14 | 115088 |